Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIAIFOD: DSA Risk Factors in Chinese Kidney Transplant Recipients
NCT04444843Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in kidney transplantation, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT04444843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04444843.